Australia markets closed

Ikena Oncology, Inc. (IKNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.6500-0.1000 (-5.71%)
At close: 04:00PM EDT
1.6600 +0.01 (+0.61%)
After hours: 05:47PM EDT
Major holders
Insider roster

Insider transactions

Currency in USD
Insider purchases - Last 6 monthsSharesTrans
Purchases00
SalesN/A0
Net shares purchased (sold)00
Total insider shares held3.38MN/A
% net shares purchased (sold)N/AN/A
Net institutional purchases - Prior quarter to latest quarterShares
Net shares purchased (sold)N/A
% change in institutional shares heldN/A

Insider transactions reported - last two years

InsiderTransactionTypeValueDateShares

BONITA DAVID P
Director

Stock Award(Grant) at price 0.00 per share.Indirect004 Aug 2023153,121

ORBIMED ADVISORS, L.L.C.
Unknown

Stock Award(Grant) at price 0.00 per share.Indirect004 Aug 2023153,121

BONITA DAVID P
Director

Purchase at price 3.55 - 5.37 per share.Indirect1,128,02124 June 2022252,225

ORBIMED ADVISORS, L.L.C.
Director

Purchase at price 3.55 - 5.37 per share.Indirect1,128,02124 June 2022252,225

TESSIER MAUDE
Officer

Conversion of Exercise of derivative security at price 2.94 - 4.51 per share.Direct253,80018 Jan 202271,786

ZHANG XIAOYAN MICHELLE
Officer

Sale at price 12.00 per share.Direct12,00011 Jan 20221,000

ZHANG XIAOYAN MICHELLE
Officer

Conversion of Exercise of derivative security at price 2.15 per share.Direct2,14611 Jan 20221,000

FORMELA JEAN FRANCOIS
Director

Sale at price 14.00 - 15.03 per share.Indirect385,57214 Dec 202126,278

ATLAS VENTURE FUND XI L.P
Beneficial Owner of more than 10% of a Class of Security

Sale at price 14.00 - 15.03 per share.Indirect385,57214 Dec 202126,278

ZHANG XIAOYAN MICHELLE
Officer

Sale at price 14.76 per share.Direct14,76010 Dec 20211,000

ZHANG XIAOYAN MICHELLE
Officer

Conversion of Exercise of derivative security at price 2.15 per share.Direct2,14610 Dec 20211,000

FORMELA JEAN FRANCOIS
Director

Purchase at price 25.60 per share.Indirect3,200,00030 Mar 2021125,000

FORMELA JEAN FRANCOIS
Director

Indirect30 Mar 20214,750,361

STAMPACCHIA OTELLO
Director

Stock Award(Grant) at price 25.60 per share.Indirect11,520,00030 Mar 2021450,000

STAMPACCHIA OTELLO
Director

Indirect30 Mar 20211,799,123

BONITA DAVID P
Director

Purchase at price 25.60 per share.Indirect10,839,04030 Mar 2021423,400

BONITA DAVID P
Director

Indirect30 Mar 20211,885,403

BONITA DAVID P
Director

Purchase at price 25.60 per share.Indirect10,839,04030 Mar 2021423,400

BONITA DAVID P
Director

Indirect30 Mar 20211,513,486

ORBIMED ADVISORS, L.L.C.
Director

Purchase at price 25.60 per share.Indirect10,839,04030 Mar 2021423,400

ORBIMED ADVISORS, L.L.C.
Director

Indirect30 Mar 20211,885,403

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 25.60 per share.Indirect10,839,04030 Mar 2021423,400

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Indirect30 Mar 20211,513,486

ATLAS VENTURE FUND X, L.P.
Beneficial Owner of more than 10% of a Class of Security

Indirect30 Mar 20214,750,361

ATLAS VENTURE FUND XI L.P
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 25.60 per share.Indirect3,200,00030 Mar 2021125,000